PAI-1 AND ANTIFIBRINOLYTIC ACTIVITY RELEASED BY PLATELETS TREATED WITH CATIONIZED HUMAN-IGG

被引：0
|
作者：
WOODS, A [1 ]
SCHATTNER, M [1 ]
LAZZARI, MA [1 ]
机构：
[1] ACAD NACL MED BUENOS AIRES,INST INVEST HEMATOL MARIANO R CASTEX,BUENOS AIRES,ARGENTINA
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1009 / 1009
页数：1
相关论文
共 50 条
  • [41] PAI-1 in human hypertension: Relation to hypertensive groups
    Srikumar, N
    Brown, NJ
    Hopkins, PN
    Jeunemaitre, X
    Hunt, SC
    Vaughan, DE
    Williams, GH
    AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (08) : 683 - 690
  • [42] IMMUNOCHEMICAL LOCALIZATION OF PAI-1 IN HUMAN-TISSUES
    SIMPSON, AJ
    BOOTH, NA
    SEWELL, H
    MACGREGOR, IR
    BENNETT, B
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 171 - 171
  • [43] The cardioprotective role of PAI-1 in human inflammatory cardiomyopathy
    Baumeier, Christian
    Aleshcheva, Ganna
    Schultheiss, Heinz-Peter
    Escher, Felicitas
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S6 - S6
  • [44] PAI activity and PAI-1 antigen both increase during a fat tolerance test: Associations with PAI-1 genotype and TGF-beta levels
    Byrne, CD
    Wareham, NJ
    Clark, PMS
    Martensz, ND
    Humphries, SE
    Metcalfe, JC
    Grainger, DJ
    ATHEROSCLEROSIS, 1997, 135 (01) : 21 - 21
  • [45] Increased PAI activity and PAI-1 antigen occurring with an oral fat load:: associations with PAI-1 genotype and plasma active TGF-β levels
    Byrne, CD
    Wareham, NJ
    Martensz, ND
    Humphries, SE
    Metcalfe, JC
    Grainger, DJ
    ATHEROSCLEROSIS, 1998, 140 (01) : 45 - 53
  • [46] Effect of combination therapy with rosiglitazone and glibenclamide on PAI-1 antigen, PAI-1 activity, and tPA in patients with type 2 diabetes
    Freed, M
    Fuell, D
    Menci, L
    Heise, M
    Goldstein, B
    DIABETOLOGIA, 2000, 43 : A267 - A267
  • [47] PAI-1 RELEASED FROM CULTURED HUMAN ENDOTHELIAL-CELLS DELAYS FIBRINOLYSIS AND IS INCORPORATED INTO THE DEVELOPING FIBRIN CLOT
    HANDT, S
    JEROME, WG
    BRAATEN, JV
    LEWIS, JC
    KIRKPATRICK, CJ
    HANTGAN, RR
    FIBRINOLYSIS, 1994, 8 (02) : 104 - 112
  • [48] Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene
    Fay, WP
    Parker, AC
    Condrey, LR
    Shapiro, AD
    BLOOD, 1997, 90 (01) : 204 - 208
  • [49] LOW-DOSE VARIANT T-PA RESISTANT TO PAI-1 - AN EFFECTIVE TREATMENT FOR PREVENTING FIBRIN DEPOSITION IN ENDOTOXIN-TREATED RABBITS WITH INCREASED PAI-1 ACTIVITY
    KRISHNAMURTI, C
    MAGLASANG, P
    KYTE, BA
    ALVING, BM
    BLOOD, 1994, 84 (10) : A245 - A245
  • [50] STABILIZATION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLATELETS AND HUMAN ERYTHROLEUKEMIC CELLS (HEL CELLS)
    LANG, IM
    CEFALU, MJ
    GOMBAU, L
    SCHLEEF, RR
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1326 - 1326
12345